Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Figure 1 | Journal of Experimental & Clinical Cancer Research

Figure 1

From: Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer

Figure 1

Expression of KIF26B in human colorectal cancer tissues and cell lines. KIF26B mRNA expression in 40 tumor tissues and paired adjacent normal mucosa (A). RT PCR analysis of KIF26B mRNA expression in eight paired colorectal tumor tissues (B). Western blot analysis of KIF26B expression in eight paired colorectal tumor tissues (C). KIF26B protein is higher in tumor tissues than in paired adjacent normal mucosa (D). KIF26B protein expression in five colorectal cell lines. Grayscale values were evaluated (n = 3, *P <0.05, compared with NCM460 cell line) (E).

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us